Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 9, 2012, Pages 1705-1708

  Simsek, Yavuz ^a   Celik, Onder ^a   Yilmaz, Ercan ^a   Karaer, Abdullah ^a   Dogan, Cagdas ^a   Aydin, Suleyman ^b   Ozer, Ali ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Apelin; Hypertension; Preeclampsia; Salusin alpha; Salusin beta

Indexed keywords

APELIN; PEPTIDE HORMONE; SALUSIN ALPHA; SALUSIN BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84860190760     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.660221     Document Type: Article

References (27)

1. Sibai BM. Preeclampsia as a cause of preterm and late preterm (nearterm) births. Semin Perinatol 2006;30:16-19.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-56. (Pubitemid 32056505)
3. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995;22:781-791.
4. Molvarec A, Rigo J Jr, Boze T et al. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost 2009;101:305-311.
5. Madach K, Molvarec A, Rigo J et al. Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol 2008;139:133-138.
6. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003;9:1166-1172. (Pubitemid 37173701)
7. Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, et al. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 2008;31:463-468. (Pubitemid 351597499)
8. Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M. Synthetic salusins as cardiac depressors in rat. Hypertension 2005;45:419-425. (Pubitemid 40315812)
9. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329-339. (Pubitemid 32772448)
10. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 2006;290:E326-E333.
11. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34-41. (Pubitemid 30012752)
12. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004;118:119-125. (Pubitemid 38296725)
13. Cobellis L, De Falco M, Mastrogiacomo A, Giraldi D, Dattilo D, Scaffa C, Colacurci N, De Luca A. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol 2007;22:1-8. (Pubitemid 46117085)
14. Liao YM, Qiao FY. [Expression of Apelin in placentas of patients with hypertensive disorders complicating pregnancy]. Zhonghua Fu Chan Ke Za Zhi 2007;42:382-385.
15. National High Blood Pressure Education Program Working Group. Report on High Blood Pressure in Pregnancy. National Institutes of Health Publication No. 00-3029. Washington DC: National Institutes of Health, 2000.
16. Yuan HT, Haig D, Ananth Karumanchi S. Angiogenic factors in the pathogenesis of preeclampsia. Curr Top Dev Biol 2005;71:297-312.
17. Mignini LE, Villar J, Khan KS. Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 2006;194:317-321. (Pubitemid 43183678)
18. Yu F, Zhao J, Yang J, Gen B, Wang S, Feng X, et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004;122:191-197. (Pubitemid 39371169)
19. Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, et al. Impact of salusinalpha and-beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008;117:638-648.
20. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996;174:1008-1013. (Pubitemid 26111684)
21. Begum S, Yamasaki M, Mochizuki M. Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia. J Obstet Gynecol Res 1996;22:551-559. (Pubitemid 27042088)
22. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001;1538:162-171. (Pubitemid 32402239)
23. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004;101:10464-10469. (Pubitemid 38924948)
24. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004;18:1909-1911. (Pubitemid 39602280)
25. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001;99:87-92. (Pubitemid 32522535)
26. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006;296:177-189. (Pubitemid 44061763)
27. Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Briana DD. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr 2007;96:1751-1754. (Pubitemid 350132045)